185
Views
3
CrossRef citations to date
0
Altmetric
Cardiovascular

The beneficial effects of renin–angiotensin system blockades on 2 year outcomes in coronary artery ectasia patients

, , , , &
Pages 1677-1684 | Received 27 Apr 2017, Accepted 07 Jun 2017, Published online: 25 Jun 2017

References

  • Swaye PS, Fisher LD, Litwin P, et al. Aneurysmal coronary artery disease. Circulation 1983;67:134-8
  • Markis JE, Joffe CD, Cohn PF, et al. Clinical significance of coronary arterial ectasia. Am J Cardiol 1976;37:217-22
  • Ozcan OU, Gulec S. Coronary artery ectasia. Cor et Vasa 2013;55:e242-7
  • Eitan A, Roguin A. Coronary artery ectasia: new insights into pathophysiology, diagnosis, and treatment. Coronary Artery Dis 2016;27:420-8
  • Kajinami K, Kasashima S, Oda Y, et al. Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases. Modern Pathology 1999;12:1174-80
  • Uyarel H, Okmen E, Tartan Z, et al. The role of angiotensin converting enzyme genotype in coronary artery ectasia. Int Heart J 2005;46:89-96
  • Diet F, Pratt RE, Berry GJ, et al. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-67
  • Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012;126:3097-137
  • Task Force on the Management of Stable Coronary Artery Disease; Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003
  • Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol 2017;69:345-57
  • Demopoulos VP, Olympios CD, Fakiolas CN, et al. The natural history of aneurysmal coronary artery disease. Heart 1997;78:136-41
  • Baman TS, Cole JH, Devireddy CM, Sperling LS. Risk factors and outcomes in patients with coronary artery aneurysms. Am J Cardiol 2004;93:1549-51
  • Sorbets E, Labreuche J, Simon T, et al. Renin–angiotensin system antagonists and clinical outcomes in stable coronary artery disease without heart failure. Eur Heart J 2014;35:1760-8
  • Kruger D, Stierle U, Herrmann G, et al. Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronopathy”). J Am Coll Cardiol 1999;34:1461-70
  • Ismail AM, Rayan M, Adel A, et al. Prevalence and pattern of abnormal myocardial perfusion in patients with isolated coronary artery ectasia: study by 99mTc-sestamibi radionuclide scintigraphy. Int J Cardiovasc Imaging 2014;30:425-30
  • Zografos TA, Korovesis S, Giazitzoglou E, et al. Clinical and angiographic characteristics of patients with coronary artery ectasia. Int J Cardiol 2013;167:1536-41
  • Xiao-Dong Z, Fei-Fei L, Zhan-Peng W, et al. Renin–angiotensin system inhibitors in patients with coronary artery disease who have undergone percutaneous coronary intervention. Ther Adv Cardiovasc Dis 2016;10:172-7
  • Lu H, Rateri DL, Bruemmer D, et al. Involvement of the renin–angiotensin system in abdominal and thoracic aortic aneurysms. Clin Sci 2012;123:531-43
  • Kundi H, Gok M, Kiziltunc E, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol 2015;116:1685-9
  • Ozbay Y, Akbulut M, Balin M, et al. The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment. Mediat Inflamm 2007;2007:89649
  • D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.